本页面由Tiger Trade Technology Pte. Ltd.提供服务

Trinity Biotech plc

0.7143
+0.01672.39%
盘后0.71430.00000.00%18:49 EDT
成交量:24.36万
成交额:17.14万
市值:1,336.48万
市盈率:-0.48
高:0.7307
开:0.6900
低:0.6583
收:0.6976
52周最高:3.44
52周最低:0.5012
股本:1,871.03万
流通股本:1,487.87万
量比:1.82
换手率:1.64%
股息:- -
股息率:- -
每股收益(TTM):-1.4937
每股收益(LYR):-1.8319
净资产收益率:-1913.45%
总资产收益率:-9.46%
市净率:-0.24
市盈率(LYR):-0.39

数据加载中...

2026/02/28

SEC问询函

Form CORRESP - Correspondence
2026/02/25

招股说明书

Form F-1 - Registration statement for certain foreign private issuers
2026/01/22

SEC问询函

Form CORRESP - Correspondence
2026/01/15

招股说明书

Form F-1 - Registration statement for certain foreign private issuers
2025/05/16

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2025/03/26

SEC问询函

Form CORRESP - Correspondence
2024/11/29

SEC问询函

Form CORRESP - Correspondence
2024/11/14

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/07/12

[修订]年度报告

Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
2024/06/27

SEC问询函

Form CORRESP - Correspondence
2024/05/03

SEC问询函

Form CORRESP - Correspondence
2024/05/01

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/04/30

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/02/09

超过5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2024/01/03

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/01/02

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/05/17

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/02/13

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/12/08

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2022/09/12

SEC问询函

CORRESP [Cover] - Correspondence